Literature DB >> 13032140

[Chemical and pharmacologic differentiation of kallikreins of various origins].

E WERLE, L MAIER.   

Abstract

Keywords:  KALLIKREIN

Mesh:

Substances:

Year:  1952        PMID: 13032140

Source DB:  PubMed          Journal:  Biochem Z        ISSN: 0366-0753


× No keyword cloud information.
  9 in total

1.  THE PRESENCE OF TWO PERMEABILITY GLOBULINS IN HUMAN SERUM.

Authors:  L J KAGEN; J P LEDDY; E L BECKER
Journal:  J Clin Invest       Date:  1963-08       Impact factor: 14.808

2.  [Recent results in the field of plasma kinins].

Authors:  I TRAUTSCHOLD; G RUDEL
Journal:  Klin Wochenschr       Date:  1963-04-01

3.  Observations on intrinsic kinin-forming factors in human plasma: the effect of acid, acetone, chloroform, heat and euglobulin separation on kinin formation.

Authors:  V Eisen
Journal:  J Physiol       Date:  1963-05       Impact factor: 5.182

4.  Characterization of Gaddum's substance R.

Authors:  G J Douglas; K I Williams; R J Flower
Journal:  Br J Pharmacol       Date:  1991-04       Impact factor: 8.739

5.  Proceedings of the British Pharmacological Society. Liverpool, 6th-8th April, 1988. Abstracts.

Authors: 
Journal:  Br J Pharmacol       Date:  1988-07       Impact factor: 8.739

6.  Initiation of plasma prorenin activation by Hageman factor-dependent conversion of plasma prekallikrein to kallikrein.

Authors:  J E Sealey; S A Atlas; J H Laragh; M Silverberg; A P Kaplan
Journal:  Proc Natl Acad Sci U S A       Date:  1979-11       Impact factor: 11.205

7.  Acute Babesia bovis infections: renal involvement in the hypotensive syndrome.

Authors:  I G Wright; B V Goodger
Journal:  Z Parasitenkd       Date:  1979-08

8.  Local kallikrein and trypsin responses in the rat.

Authors:  A J Bennett; G B West
Journal:  Br J Pharmacol       Date:  1980-08       Impact factor: 8.739

9.  PRESENCE OF KALLIKREIN IN THE GAMMA-GLOBULIN PERMEABILITY FACTOR OF GUINEA-PIG SERUM.

Authors:  G E DAVIES; J S LOWE
Journal:  Br J Pharmacol Chemother       Date:  1963-12
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.